Paradoxical decrease in isoprostane and increase in superoxide dismutase following CPAP withdrawal in OSA.
We thank Monneret and Bonnefont-Rousselot for their commentary. Our controlled trial design overcomes most of their concerns of course; any failure of assay techniques would not have produced a biased result, but in fact would have decreased the chances of finding any between-group effects. In our s...
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Journal article |
| 言語: | English |
| 出版事項: |
European Respiratory Society
2016
|